Illumina

Senior Territory Account Manager - Belgium - Dutch Speaking

Belgium

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Medical Devices, HealthcareIndustries

Requirements

Candidates should possess a Bachelor's or Master's degree in Life Sciences or a related field, with demonstrated experience in Life Science or Diagnostics sales or a related area. Fluency in both Dutch and English languages is required, along with a valid driver's license. Strong technical knowledge in molecular biology is preferred.

Responsibilities

As a Senior Territory Account Manager, responsibilities include developing high-value customer clinical accounts, identifying and managing sales opportunities, conducting customer sales presentations, negotiating sales contracts, maintaining customer account details in the CRM database, providing sales forecasts, creating territory business plans, and leveraging CRM to grow sales and expand the customer base. The role also involves coordinating sales activities, providing product and technology training, and working collaboratively with sales management and other specialists.

Skills

Life Sciences
Diagnostics
Sales
Customer Relationship Management
Hospital Market Knowledge
Translational Research
Pathology

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI